NR 507 ADVANCED PATHOPHYSIOLOGY PRACTICE QUESTIONS &
ANSWERS BUNDLE | LATEST 2025–2026 EXAM PREP |
COMPREHENSIVE STUDY GUIDE WITH VERIFIED RATIONALES | WEEK-
BY-WEEK REVIEW | GUARANTEED SUCCESS RESOURCE
WHICH BEST DESCRIBES A TYPE 1 HYPERSENSITIVITY REACTION?
A. IGG-MEDIATED CYTOTOXIC REACTION
B. IMMUNE COMPLEX DEPOSITION IN TISSUES
C. IGE-MEDIATED IMMEDIATE ALLERGIC REACTION
D. DELAYED T-CELL-MEDIATED RESPONSE
CORRECT ANS: C. IGE-MEDIATED IMMEDIATE ALLERGIC REACTION
FEEDBACK: TYPE 1 HYPERSENSITIVITY REACTIONS OCCUR WITHIN MINUTES AND
INVOLVE IGE ANTIBODIES AND MAST CELL DEGRANULATION
SELECT ALL THAT APPLY:
WHICH FINDINGS ARE CONSISTENT WITH ANAPHYLAXIS?
A. HYPOTENSION
B. BRONCHOCONSTRICTION
C. BRADYCARDIA
D. URTICARIA
E. INCREASED MUCUS PRODUCTION
CORRECT ANS: A. HYPOTENSION
B. BRONCHOCONSTRICTION
D. URTICARIA
, E. INCREASED MUCUS PRODUCTION
FEEDBACK: ANAPHYLAXIS CAUSES VASODILATION, BRONCHOCONSTRICTION, HIVES,
AND INCREASED MUCUS PRODUCTION.
SELECT ALL THAT APPLY:
WHICH DISEASES ARE ASSOCIATED WITH TYPE 2 HYPERSENSITIVITY?
A. MYASTHENIA GRAVIS
B. SYSTEMIC LUPUS ERYTHEMATOSIS (SLE)
C. HEMOLYTIC ANEMIA
D. GRAVE'S DISEASE
E. CONTACT DERMATITIS
CORRECT ANS: A. MYASTHENIA GRAVIS
C. HEMOLYTIC ANEMIA
D. GRAVE'S DISEASE
FEEDBACK: TYPE 2 HYPERSENSITIVITY TARGETS SPECIFIC CELLS USING IGG OR IGM
ANTOBODIES
SELECT ALL THAT APPLY:
WHICH ARE CLINICAL MANIFESTATIONS OF HIV?
A. DECREASED CD4 COUNT
ANSWERS BUNDLE | LATEST 2025–2026 EXAM PREP |
COMPREHENSIVE STUDY GUIDE WITH VERIFIED RATIONALES | WEEK-
BY-WEEK REVIEW | GUARANTEED SUCCESS RESOURCE
WHICH BEST DESCRIBES A TYPE 1 HYPERSENSITIVITY REACTION?
A. IGG-MEDIATED CYTOTOXIC REACTION
B. IMMUNE COMPLEX DEPOSITION IN TISSUES
C. IGE-MEDIATED IMMEDIATE ALLERGIC REACTION
D. DELAYED T-CELL-MEDIATED RESPONSE
CORRECT ANS: C. IGE-MEDIATED IMMEDIATE ALLERGIC REACTION
FEEDBACK: TYPE 1 HYPERSENSITIVITY REACTIONS OCCUR WITHIN MINUTES AND
INVOLVE IGE ANTIBODIES AND MAST CELL DEGRANULATION
SELECT ALL THAT APPLY:
WHICH FINDINGS ARE CONSISTENT WITH ANAPHYLAXIS?
A. HYPOTENSION
B. BRONCHOCONSTRICTION
C. BRADYCARDIA
D. URTICARIA
E. INCREASED MUCUS PRODUCTION
CORRECT ANS: A. HYPOTENSION
B. BRONCHOCONSTRICTION
D. URTICARIA
, E. INCREASED MUCUS PRODUCTION
FEEDBACK: ANAPHYLAXIS CAUSES VASODILATION, BRONCHOCONSTRICTION, HIVES,
AND INCREASED MUCUS PRODUCTION.
SELECT ALL THAT APPLY:
WHICH DISEASES ARE ASSOCIATED WITH TYPE 2 HYPERSENSITIVITY?
A. MYASTHENIA GRAVIS
B. SYSTEMIC LUPUS ERYTHEMATOSIS (SLE)
C. HEMOLYTIC ANEMIA
D. GRAVE'S DISEASE
E. CONTACT DERMATITIS
CORRECT ANS: A. MYASTHENIA GRAVIS
C. HEMOLYTIC ANEMIA
D. GRAVE'S DISEASE
FEEDBACK: TYPE 2 HYPERSENSITIVITY TARGETS SPECIFIC CELLS USING IGG OR IGM
ANTOBODIES
SELECT ALL THAT APPLY:
WHICH ARE CLINICAL MANIFESTATIONS OF HIV?
A. DECREASED CD4 COUNT
